Regeneron Pharmaceuticals, Inc. (REGN)

952.4 USD-0.32%close 2026-11-16Healthcare
Gurus hold1popularity #855 of 1982
Net buying (quarter)−$73.3M0 buying · 1 selling
Market Cap$100.57B52 Week Range: 600.66 – 973.36
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.21.07Dividend Yield: 0.39%
The live quote provider is unreachable; the last known close is shown.

Regeneron Pharmaceuticals, Inc. (REGN) is not among the 30 most-held stocks of the tracked superinvestor set. Price 952.40 USD; market cap $100.57B.

Guru Ownership

Popularity rank#855 of 1,982 securities
gurus hold it1
Net activity this quarter−$73.3M

Guru count: the consensus-panel funds (wide books such as Citadel or Renaissance excluded) holding the stock at quarter end; the header and the history table use the same definition.

What changed this quarter
$0.00 · 0 new buys · 0 added $73.3M · 1 reduced · 0 sold out0 net buyers · 1 net sellers
Top 5 by conviction
Dodge & Cox1.9%Reduced -2.0%
Top 5 by value
Dodge & Cox$3.62BReduced -2.0%
Ownership by quarter · 72 funds with stored history
Report forgurus hold itTotal ValueAvg Weight
2017-09-301$14.2M0.7%
2017-12-311$961.2M2.9%
2018-03-311$827.9M2.5%
2018-06-301$795.5M2.3%
2018-09-301$879.8M2.5%
2018-12-312$1.33B3.2%
2019-03-312$1.47B3.0%
2019-06-302$800.1M1.6%
2019-09-302$702.3M1.4%
2019-12-312$949.6M1.7%
2020-03-313$1.28B2.1%
2020-06-303$1.70B1.8%
2020-09-304$1.96B1.4%
2020-12-312$1.22B1.4%
2021-03-312$510.6M0.6%
2021-06-302$844.4M0.9%
2021-09-303$848.9M0.6%
2021-12-314$1.06B0.5%
2022-03-314$2.38B0.7%
2022-06-303$1.73B0.7%
2022-09-303$1.76B0.7%
2022-12-313$1.69B0.5%
2023-03-313$1.99B0.5%
2023-06-303$1.74B0.4%
2023-09-302$1.98B0.8%
2023-12-313$2.12B0.6%
2024-03-313$2.30B0.6%
2024-06-302$2.45B0.8%
2024-09-303$2.50B0.6%
2024-12-312$1.66B0.5%
2025-03-313$1.54B0.4%
2025-06-303$2.02B0.8%
2025-09-302$2.57B0.7%
2025-12-312$3.55B1.0%
2026-03-311$3.44B1.9%
2026-06-301$3.04B1.6%
2026-09-301$3.62B1.9%

Price & valuation

Prev Close955.46
Open—
Day Range—
52 Week Range600.66 – 973.36
Volume—
Avg Volume (3M)—
Market Cap$100.57BSEC 10-Q, 09/30/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.522 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.21.07SEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.45.21SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.0.39%SEC 10-Q, 09/30/2026

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own REGN?

Regeneron Pharmaceuticals, Inc. (REGN) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on REGN bullish or bearish?

REGN is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.